Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK 1024850A vs Prevenar Booster at 4 Years
NCT00907777Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2009
- Primary completion
- Oct 2009
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Jun 2009; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00907777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907777.